 |
|
Virendra I. Patel, MD Instructor in Surgery, Harvard Medical School
Division of Vascular and Endovascular Surgery
(617) 643-6110 p
(617) 643-6111 f
vpatel4@partners.org
Clinical Background:
MD: Tufts University School of Medicine
Residency: Beth Israel Deaconess Medical Center, 1998-2006
Fellowship: Massachusetts General Hospital (Vascular Surgery), 2006-2008
Clinical Interests:
Vascular/endovascular surgery; thoracic/thoracoabdominal/abdominal aortic aneurysm repair and other aortic pathology; renal and visceral vascular disease; carotid disease; peripheral vascular disease.
Research:
Clinical outcomes in vascular and endovascular surgery; local and systemic vascular responses to injury and inflammation.
Recent Publications:
"A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia." FASEB J. July 2006. Vol. 20(9): 1418-30. VI Patel MD, S Daniel PhD, CR Longo MD, GV Shrikhande MD, ST Scali MD, E Csizmadia, CM Groft MD, T Shukri, C Motley-Dore, HE Ramsey, MD Fisher MD, ST Grey PhD, MB Arvelo MD, C Ferran MD PhD
"The universal NF-kappaB inhibitor A20 protects from transplant vasculopathy by differentially affecting apoptosis in endothelial and smooth muscle cells." Transplant Proc. 2006. Dec; 38(10):3225-7. Daniel S, Patel VI, Shrikhande GV, Scali ST, Ramsey HE, Csizmadia E, Benhaga N, Fisher MD, Arvelo MB, Ferran CF MD PhD
"Lower Extremity Arterial Revascularization in Obese Patients." Journal of Vascular Surgery. October 2007; 46:738-42. VI Patel MD, C. Hile MD, S Szwarc PhD, D. Campbell MD, M. Schermerhorn MD, S. Scovell MD, F. LoGerfo MD, F. Pomposelli MD, A. Hamdan MD
"Surgical Endarterectomy: The Preferred Treatment for Common Femoral Artery Occlusive Disease." Journal of Vascular Surgery. 2008 J Kang, VI Patel, MF Conrad, GM LaMuraglia, CJ Kwolek, DC Brewster, TK Chung, RP Cambria.
back to top |